A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases.
Zin W MyintRiham El KhouliBryan LemieuxDonglin YanWilliam H St ClairXiaoqi LiuCharles A KunosPublished in: BMC cancer (2022)
ClincialTrials.gov Identifier: NCT04616547.